Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy

Author： Kaminow L.   Schimschock J.R.   Hammer A.E.   Vuong A.  

Publisher： Elsevier

ISSN： 1525-5050

Source： Epilepsy & Behavior, Vol.4, Iss.6, 2003-12, pp. : 659-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy

By Nieto-Barrera M.   Brozmanova M.   Capovilla G.   Christe W.   Pedersen B.   Kane K.   O'Neill F.   on behalf of the Lamictal vs Carbamazepine Study Group  

Epilepsy Research, Vol. 46, Iss. 2, 2001-08 ,pp. : 145-155

Elsevier

Access to resources Recommend Favorite

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy

By Reunanen M.   Dam M.   Yuen A.W.C.  

Epilepsy Research, Vol. 23, Iss. 2, 1996-03 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Metabolite profiles in patients on high-dose valproate monotherapy

By Sugimoto T.   Muro H.   Man W.   Nishida N.   Murakami K.  

Epilepsy Research, Vol. 25, Iss. 2, 1996-10 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy

By Morrell M.J.   Isojarvi J.   Taylor A.E.   Dam M.   Ayala R.   Gomez G.   O'Neill F.   Tennis P.   Messenheimer J.  

Epilepsy Research, Vol. 54, Iss. 2, 2003-05 ,pp. : 189-199

Elsevier

Access to resources Recommend Favorite

Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy

By Gidal B.E.   Anderson G.D.   Rutecki P.R.   Shaw R.   Lanning A.  

Epilepsy Research, Vol. 42, Iss. 1, 2000-11 ,pp. : 23-31

Elsevier

Access to resources Recommend Favorite